• Explore /
  • Poster
  • / SWOG S1115: Randomized phase II clinical trial of selumetinib (AZD6244; ARRY 142886) hydrogen sulfate (NSC-748727) and MK-2206 (NSC-749607) versus mFOLFOX in patients withmetastatic pancreatic cancer after prior chemotherapy.

SWOG S1115: Randomized phase II clinical trial of selumetinib (AZD6244; ARRY 142886) hydrogen sulfate (NSC-748727) and MK-2206 (NSC-749607) versus mFOLFOX in patients withmetastatic pancreatic cancer after prior chemotherapy.

Abstract Poster

Authors

null

Vincent M. Chung

City of Hope, Duarte, CA

Vincent M. Chung , Shannon McDonough , Philip Agop Philip , Dana Backlund Cardin , Andrew M. Lowy , Jacqueline K. Benedetti , Charles Davic Blanke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT01658943

Citation

J Clin Oncol 31, 2013 (suppl; abstr TPS4145)

DOI

10.1200/jco.2013.31.15_suppl.tps4145

Abstract #

TPS4145

Poster Bd #

31G

Abstract Disclosures

Similar Posters

First Author: Vincent M. Chung

First Author: Inhwang Hwang

First Author: Lars Henrik Jensen

First Author: Jean-Luc Van Laethem